The marketing system for original drugs is established to be responsible for the marketing and promotion of imported original drugs in China.
Zhejiang Hesenna Medicine Co., Ltd. (HSN) was established in Lishui City, Zhejiang Province in 2020, and it is committed to building a pharmaceutical enterprise that provides integrated services for the registration and marketing, import transportation, brand promotion of original patented drugs in China.
The marketing system for original drugs is established to be responsible for the marketing and promotion of imported original drugs in China.
Focusing on core product lines: osteoporosis, nephrology, oncology and psychiatry, continuously introducing high-quality products, using professional promotion to serve more doctors and benefit more patients!
Reaching strategic cooperation with multiple Marketing Authorization Holders (MAHs), and obtaining commercialization rights for multiple original drugs in China;
The projects implemented include Rocaltrol® (Calcitriol Soft Capsules), Wakix® (Pitolisant Hydrochloride Tablets), Rivotril (Clonazepam), Carmustine Injection (Complex Product), Oxygen-Carrying Organ Preservation Solution, etc.
The “Integrated Osteoporosis Diagnosis and Treatment Plan” strategy is launched, focusing on bone health management.
Continuously introducing high-end products and reaching project cooperation with Pharmanovia, Cheplapharm, Bioprojet, Patheon, Inpharmasci.
The “Bone Transformation, Vitality Renewal” project was launched, increasing the market share of Bondronat from the lowest to the first in the same product, with a market share exceeding 32%.
Zhejiang Hesenna Medicine Co., Ltd. was incorporated to be fully responsible for the government affairs, registration application, and marketing promotion of Roche’s original drug brands Bondronat and Bonviva, and has achieved results!
Based in China and facing the world, HSN is a pharmaceutical group that provides integrated services of Commercialization, supply chain, and brand promotion of foreign high-end patented drugs in China. An emerging strategic partner for your brand.
Copyright © 2024 – Hesenna Medicine All rights reserved.
